BCA
AGN

Bray Capital Advisors’s Allergan plc AGN Stock Holding History

Bray Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31
Closed -$5K – 341
2019
Q3 		$5K Hold
31
– – ﹤0.01% 301
2019
Q2 		$5K Hold
31
– – ﹤0.01% 318
2019
Q1 		$5K Buy
+31
New +$4.49K ﹤0.01% 306

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bray Capital Advisors's AGN Position: Q4 2019 in Review

Bray Capital Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 31 shares — an estimated $5K sold.

Bray Capital Advisors first reported a position in AGN in Q1 2019 and held it in 3 quarters. The position peaked at $5K in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Bray Capital Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Bray Capital Advisors sold 31 Allergan plc shares in Q4 2019, an estimated $5K.
  • Bray Capital Advisors first reported a position in Allergan plc in Q1 2019 and held it in 3 quarters.
  • Bray Capital Advisors's Allergan plc position peaked at $5K in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Bray Capital Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.